Active Psoriatic arthritis Completed Phase 3 Trials for Certolizumab pegol (DB08904)

Also known as: Psoriatic arthritis aggravated / Psoriatic arthropathy aggravated / Psoriatic arthropathy NOS (disorder) / Psoriatic arthropathy / Arthropathy psoriatic / Psoriatic arthritis / Psoriasis with arthropathy (disorder) / Arthritis, Psoriatic / Psoriatic arthropathies / Arthropathic psoriasis / Arthropathic psoriasis, unspecified

IndicationStatusPhase
DBCOND0020384 (Active Psoriatic arthritis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03357471Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's DiseaseTreatment